Francisco A. Conde, Ph.D.
Affiliations: | 2003 | University of California, Los Angeles, Los Angeles, CA |
Area:
Nursing, Oncology, EpidemiologyGoogle:
"Francisco Conde"Parents
Sign in to add mentor| Linda Sarna | grad student | 2003 | UCLA | |
| (Changes in bone mineral density in men with prostate cancer during treatment with luteinizing hormone -releasing hormone (LHRH) agonist monotherapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Conde FA, Landier W, Ishida D, et al. (2011) Barriers and facilitators of prostate cancer screening among Filipino men in Hawaii. Oncology Nursing Forum. 38: 227-33 |
| Foster J, Conde F. (2008) Providing psychosocial support to men with prostate cancer and their wives. Hawaii Medical Journal. 67: 80 |
| Henning SM, Aronson W, Niu Y, et al. (2006) Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. The Journal of Nutrition. 136: 1839-43 |
| Aronson WJ, Freedland SJ, Conde F, et al. (2005) 1417: Growth Inhiditory Effects of a Low-Fat Diet on Prostate Cancer Cells in Vitro: Results of a Prospective Randomized Dietary Intervention Trial in Men with Prostate Cancer The Journal of Urology. 173: 384-384 |
| Conde FA, Sarna L, Oka RK, et al. (2004) Age, body mass index, and serum prostate-specific antigen correlate with bone loss in men with prostate cancer not receiving androgen deprivation therapy. Urology. 64: 335-40 |
| Conde FA, Aronson WJ. (2003) Risk factors for male osteoporosis. Urologic Oncology. 21: 380-3 |
| Gholz RC, Conde F, Rutledge DN. (2002) Osteoporosis in men treated with androgen suppression therapy for prostate cancer. Clinical Journal of Oncology Nursing. 6: 88-93 |